FDA Investigator Dawn E Barkans

Dawn E Barkans has inspections in 5 countries as of 12 Mar 2024. Dawn E Barkans has collaborated with a combinined 4599 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
148
Last Inspection Date:
12 Mar 2024
Investigator Role:
FDA Investigator
Redica ID:
Country:
Japan, United States of America, India, Australia, Thailand
Co-Investigator(s):
Abby M Miller, Ademola O Daramola, Alan D Grupe, Alexander M Kay, Alicia A Borg Borm, Aliza Chalapong Asawesna, Andrew K Haack, PhD, Anita Narula, PhD, Ariel Cruz Figueroa, Arthur G Hurst, Ashar P Parikh, Astrida B Mattson, Atrida B Mattson, Avery J Dennis, Barbara J Rincon, Barbara Janine Breithaupt, Bichsa T Tran, Bijoy Panicker, Blondell W Johnson, Bradley Dworak, PhD, Brenda L Reihing, Bruce R Burrell, Bryan L Mcguckin, Burbach, Camille Bennett Hoffman, Carl A Anderson, Carmen Y Fisher, Caryn M Mcnab, Ce'nedra M Martin, Celia L Hutchinstein, Charisse K Green, Charles M Edwards, Christian D Lynch (CDL), Christie A Soto, Christine A Harman, PhD, Christopher R Czajka, Christopher S Keating, Clinton R Vanblaricom, Conner N Mann, Connie P Rezendes, Connie P Rezenes, Crystal A Harlan, Cynthia J Lee, MS, Dam S Barkans, Daniel J Moskowitz, Danielle Lyke, David A Quale, David J Gomes, David J Hajduk, David L Hunsaker, Deborah A Nebenzahl, Devon Jenkins, Devon M Shoop, Dianna D Wardlow Dotter, Dianne B Latona, Dipesh K Shah, Dirk L Lincoln, Dolores E Price, Don A Brunssen, Don H Bark, PhD, Donald B Mckechnie, Dov H Pluznik, PhD, Edwin Melendez, Eileen A Liu, Elizabeth S Howell, Emil P Wang, JD, Eric L Dong, BS, Eric S Myskowski, Erik W Koester, Erika V Butler, Gerard Pde Leon, Gilbert T Salud, Gloria J Baca, MS, Gordon T Wales, Hanna L Dotter, Hanna L Potter, Harmon M Blanch, Heika R Bounds, Heika R Tait, Heika Tait, Hugh A Grimoldby, Hugh Grimoldby, Hughes, Ian J Thomson, Ismael Olvera, IV, Israel Santiago, OCM, Jacek Cieslak, PhD, Jacqueline Mdiaz Albertini, James A Lentz, James C Henry, James C Maclaughlin, James D Hildreth, James E Trabert, James I Vik, James S Cartwright, James S Stuart, BS, Jane M Kreis, Jason D Tenney, Jeanne M Weishaar, Jeannie Pradyanata, Jeannine K Wooten, Jeffrey J Leclair, Jennifer L Bridgewater, Jennifer L Gustavus, Jessica B Clark, Jinkee Mvila Binayug, Joey V Quitania, John A Gonzalez, John A Hall, John Burr, John D White, John E Emmert, John W Banks, Jonathan T Little, Joshua P Wireman, Julia E Chervoni, Julian C Hanson, June H Wetherington, Justin A Boyd, Justin A Hefferman, Kaitlyn R Kornberg, Kara D Dobbin, Kari M Johansen, Katherine L Arnold, Katherine Szestypalow, Kathryn A Krentz, Keegan B Mixon, Kelsey A Volkman, Kelsey M Bishop, Kenneth O Gee, PhD, Kham Phommachanh, Kim Lthomas Cruse, Kimberly J Proctor Jones, Kristin M Abaonza, Lance W Bohm, Larry K Austin, Laurel A Beer, Lauren E Swantko, Lawrence Y Lee, PhD, LCDR Debra Emerson, LCDR Michael H Tollon, Leon R Marquart, Lesley A Swanson, Leya A Grosch, Liming Zhang, Linda F Murphy, Linda S Leja, Lisa A Bowden, Lisa K Capron, Lisa Shin, Lori J Silverstein, Lynda L Perry, PhD, Marcus A Goshen, Margo C Jones, Margo Cl Jones, Maria Pkelly Doggett, MBA, Marijo B Kambere, PhD, Mariza M Jafary, Marjorie A Shapiro, PhD, Mark E Imsland, Mark E Moen, Mark L Collins, Mark W Babbitt, Marvin D Jones, Mary E Farbman, PhD, Matthew B Casale, Matthew R Mcnew, Maxine H Wong, Michael J Donovan, Michael S Hudson, Michael S Smoker, Miguel A Martinez, Mihaly S Ligmond, Mikel T Wright, Misty L Treece, Misty L Wallace, Muralidhara B Gavini, PhD, Nadeem I Chaudhry, Nancy A Saxenian Emmons, Nancy E Byerly, Nicholas L Hunt, Nicole E Knowlton, Niketa Patel, Noreen Muniz, Omotunde O Osunsanmi, Orval D Mcintire, Pal S Mayasandra, Paul F Rader, Paul M Kawamoto, Paul Rader, Paula A Trost, Paula J Wilkerson, Peter C Chow, Philip E Ake, Phillip J Dugger, Prabhu P Raju, Rachelle M Deskins, Ralph H Vocque, Randy L Self, Rebecca Rodriguez, Rebecca T Davis, Richard A Martin, Richard G Runyon, Robert A Williams, Robert C Coleman, Robert D Tollefsen, Rocco C Black, Roger F Zabinski, Rohit A Mathew, Ronald E Gill, Ross J Grigsby, Rowena S Nguyen, S Lori Brown, PhD MPH, Sandra A Hughes, Sangeeta M Khurana, PhD, Sangeeta M Rataul, Santos E Camara, Sara H Gabel, Savini, Scott W Fox, Shannon J Hall, Sharon I Gundersen, Shelagh D Schopen, Shelton L Stribling, Sherri N Rohlf, MD, Sonia R Peterson, State Agency, Stephanie A Jameson, Stephen D Weagant, Stephen J Koniers, Sunitha K Rajaram, PhD, Susan F Laska, MS, Susant Hadman, Tara M Pianko, Terri L Dodds, Terry L Dodds, Thomas C Mclean, CFS, Thomas J Arista, Timothy D Evans, Tina S Roecklein, Tracy K Li, Tsz Kwan K Ngan, Uttaniti Limchumroon (Tom), V Teres Speer, Vanessa Y Gelsey, PhD, Vanessa Y Jacobs, Virgilio F Pacio, CSO, Vitaliy N Guyvan, Walden H Lee, Wayne S Fortenberry, Wendy G Tan, PhD, Willis L Hicks, Xiaojun Yan, Xiomara Copeland, Young Kim, Yvette I Johnson, Zachary L Stamm, Zedong Dong, Zhaoyang Meng, Zhongren Wu

Dawn E Barkans's Documents

Publish Date Document Type Title
March, 2005 FDA 483 Keeler's Medical Supply, Inc - Form 483, 2005-03-17
June, 2015 FDA 483 SEAGEN INC. - Form 483, 2015-06-09
August, 2002 EIR WCG IRB, Inc - EIR, 2002-08-23
November, 2003 EIR AAA Laboratory - EIR, 2003-11-24
October, 2004 FDA 483 D.N.A. LAB INC. - Form 483, 2004-10-25
March, 2007 FDA 483 RNA BIO/PHARMA INC. - Form 483, 2007-03-08
November, 2003 EIR La Haye Laboratories Inc - EIR, 2003-11-17
August, 2002 EIR US Foods Inc - EIR, 2002-08-01
September, 2006 FDA 483 OFD Biopharma, LLC - Form 483, 2006-09-22
May, 2002 EIR Integra Chemical Company - EIR, 2002-05-21
August, 2002 FDA 483 Response WCG IRB, Inc - Form 483R, 2002-09-19
January, 2003 EIR Jubilant HollisterStier LLC - EIR, 2003-01-24
September, 2006 FDA 483 Response OFD Biopharma, LLC - Form 483R, 2006-09-22
August, 2002 FDA 483 Spokane Produce, Inc. - Form 483, 2002-08-09
December, 2002 FDA 483 Immunex Corp. - Form 483, 2002-12-18
October, 2006 EIR Jubilant HollisterStier LLC - EIR, 2006-10-11
January, 2005 EIR Immunex Corp. - EIR, 2005-01-20
August, 2002 EIR Spokane Produce, Inc. - EIR, 2002-08-16
May, 2002 FDA 483 Response Integra Chemical Company - Form 483R, 2002-06-25
December, 2002 FDA 483 Response Immunex Corp. - Form 483R, 2003-01-06
April, 2003 FDA 483 Jubilant HollisterStier LLC - Form 483, 2003-04-11
October, 2003 EIR Nitrox, Inc. - EIR, 2003-10-28
November, 2007 FDA 483 Pascal Company, Inc. - Form 483, 2007-11-02
April, 2008 FDA 483 Kirkman Laboratories, Inc. - Form 483, 2008-04-09
January, 2003 FDA 483 Jubilant HollisterStier LLC - Form 483, 2003-01-24
June, 2015 EIR SEAGEN INC. - EIR, 2015-06-09
June, 2006 FDA 483 OFD Biopharma, LLC - Form 483, 2006-06-16
June, 2006 EIR OFD Biopharma, LLC - EIR, 2006-06-18
September, 2006 EIR WCG IRB, Inc - EIR, 2006-09-01
August, 2002 FDA 483 Western Institutional Review Board, Inc. - Form 483, 2002-08-23
January, 2003 FDA 483 Response Jubilant HollisterStier LLC - Form 483R, 2003-01-28
October, 2004 FDA 483 RNA BIO/PHARMA INC. - Form 483, 2004-10-25
September, 2004 FDA 483 Evangelical Christian Ministry dba Health & Herbs - Form 483, 2004-09-17
April, 2003 FDA 483 Response Jubilant HollisterStier LLC - Form 483R, 2003-04-22
May, 2002 FDA 483 Integra Chemical Company - Form 483, 2002-05-21
April, 2003 EIR Jubilant HollisterStier LLC - EIR, 2003-04-11
June, 2015 FDA 483 Response SEAGEN INC. - Form 483R, 2015-06-26
September, 2006 EIR OFD Biopharma, LLC - EIR, 2006-09-22
October, 2003 FDA 483 Nitrox, Inc. - Form 483, 2003-10-29

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more